(Q34565175)

3 August 2017

1 reference

title

Imiquimod in the treatment of lentigo maligna (English)

1 reference

3 August 2017

1 reference

S F Rajpar

1

1 reference

3 August 2017

J R Marsden

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

British Journal of Dermatology

3 August 2017

published in

1 reference

3 August 2017

volume

155

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

653-656

1 reference

Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Melanotic freckle of Hutchinson

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Survey of U.K. current practice in the treatment of lentigo maligna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Extensive lentigo maligna clearing with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Treatment of lentigo maligna with topical imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Topical imiquimod immunotherapy in the management of lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

A pilot study of treatment of lentigo maligna with 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Successful treatment of persistent melanoma in situ with 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Imiquimod in the treatment of extensive recurrent lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Image in clinical medicine. Lentigo maligna

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Topical imiquimod in the treatment of metastatic melanoma to skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Viral and nonviral uses of imiquimod: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

Radiation therapy for malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07476.X

10.1111/J.1365-2133.2006.07476.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference